Par Pharmaceutical (PRX) Peers On Watch After Deal (TEVA) (MYL) (WPI)
Tweet
Share
E-mailGet Alerts PRX Hot Sheet
Join SI Premium – FREE
Par Pharmaceutical Companies Inc. (NYSE: PRX) peers are on watch following the acqusition of the company by TPG for $50 per share, or a 37% premium.
Teva Pharmaceutical Industries (Nasdaq: TEVA), Sandoz Pharmaceuticals, Mylan Laboratories (NYSE: MYL), and Watson Pharmaceuticals (NYSE: WPI).
Teva Pharmaceutical Industries (Nasdaq: TEVA), Sandoz Pharmaceuticals, Mylan Laboratories (NYSE: MYL), and Watson Pharmaceuticals (NYSE: WPI).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- Prime Video to invest $2 billion in Latin America by 2030
- Holcim said to acquire part of James Hardie's EU business
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
